维普中文期刊产品整合服务
68篇 您的检索式:作者名="Ohman D"
    题名 作者 年代 出处 被引量
1动脉粥样硬化血栓形成门诊患者1年内心血管事件的发生率显示文摘背景:目前,有关社区中动脉粥样硬化血栓形成稳定患者心血管(cardiovascular,CV)事件发生率的资料比较少,既往也无国际性队列研究对冠状动脉病(coronary artery disease,CAD)、脑血管病(cerebrovascular disease,CVD)、外周动脉病(peripheral arterial disease,PAD)确诊患者以及此类疾病高危患者不同事件的发生率进行评估。 目的:在患有动脉疾病的门诊患者或存在多个动脉粥样硬化血栓形成危险因素的门诊患者中确定当今世界1年内CV事件的发生率。 设计、地点及参试者:“减少动脉粥样硬化血栓形成维系健康(Reduction of Artherotllrombosis for Continued Health,REACH)”注册研究是一项国际前瞻性队列研究。研究人员于2003—2004年从44个国家、5587名医生入选68236例已确诊的动脉粥样硬化性血管病患者(CAD、PAD、CVD;n=55814)以及至少存在3个动脉粥样硬化血栓形成危险因素的患者(n=12422)。 主要观测指标:CV死亡、心肌梗死(myocardial infarction,MI)及卒中的发生率。结果:截至2006年7月,共有95.22%的患者(n=64977)提供了1年内的结局。心血管死亡、MI及卒中的总体发生率为4.24%;动脉粥样硬化性血管病患者为4.69%,仅存在多个危险因素的患者为2.15%。CAD、CVD及PAD患者CV死亡、MI及卒中的总体发生率分别为4.52%、6.47%和5.35%。CAD、CVD及PAD患者发生终点事件(即CV死亡、MI、卒中)以及因动脉粥样硬化血栓形成事件入院的几率分别为15.20%、14.53%和21.14%。上述事件发生率随症状性动脉疾病病变部位数量的增加而增加,仅存在危险因素的患者为5.31%,有1处症状性动脉疾病的患者为12.58%,有2处症状性动脉疾病的患者为21.14%,有3处症状性动脉疾病的患者为26.27%(趋势P〈0.001)。 结论:在这项当代大型国际研究中,患有动脉粥样硬化性血管病的门诊患者以及有动脉粥样硬化血栓形成危险的门诊患者CV事件的年发生率相对较高。存在多部位病变者CV事件的1年发生率升高。Gabriel Steg Deepak L. Bhatt Peter W. F. Wilson Ralph D' Agostino E. Magnus Ohman Joachim Roether Chiau-Suong Liau Alan T. Hirsch Jean-Louis Mas Yasuo Ikeda Michael J. Pencina Shinya Goto 徐成斌(译) 李呈亿(校) 2007美国医学会杂志(中文版)2007,26,4:20
2Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography:a secondary,prespecified analysis of the TRILOGY ACS trial显示文摘Wiviott S D White H D Ohman E M 2013Lancet2013,382,9892:1
3Platelet function during extended prasugrel and clopidogrel therapy for patients with acs treated without revascularization: the trilogy acs platelet function substudy 显示文摘GURBEL P A ERLINGE D OHMAN E M 2012JAMA2012,308,17:1
4The face in the crowd revisited:A threat advantage with schematic stimuli显示文摘OHMAN A LUNDQVIST D ESTEVES F 2001Journal of Personality and Social Psychology2001,80,3:1
5Determination of serum reboxetine enantiomers in patients on chronic medication with racemic reboxetine显示文摘OHMAN D CHERMA MD NORLANDER B 2003Ther Drug Monit2003,25,2:1
6The demographic benefits of vertical migration by zooplankton显示文摘OHMAN M D 1990Ecological Monographs1990,60,:1
7Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy显示文摘Gurbel PA Erlinge D Ohman EM 2012Jama2012,308,:1
8Transcriptional analysis of the Pseudomonas aeruginosa genes algR,algB,and algD reveals a hierarchy of alginate gene expression which is modulated by algT显示文摘Wozniak D J Ohman D E 1994J Bacteriol1994,176,:1
9Mutant analysis and cellular localization of the AlgI,AlgJ,and AlgF proteins required for O acetylation of alginate in Pseudomonas aeruginosa显示文摘Franklin M J Ohman D E 2002J Bacteriol2002,184,11:1
10Targeting MCP-1 to reduce vascular com- plications of obesity显示文摘Ohman M K Eitzman D T 2009Recent Pat Cardiovasc Drug Discov2009,4,3:1
11FimH family of type 1 fimbrial adhesins: functional heteroge- neity due to minor sequence variations among firnH genes 显示文摘Sokurenko E V Courtney H S Ohman D E 1994Journal of bacteriology1994,176,3:1
12Concordance between core labs in trial results using TIMI flow grades and frame counts显示文摘Moliterno D Antman EM Ohman M 2000Circulation2000,102,:1
13Faciliatation of early pereutaneous coronary intervention after reteplasc with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) trial显示文摘HEEMANN H C MOLITERNO D J OHMAN E M 2000J Am Coil Cardiol2000,36,:1
14Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy 显示文摘Gurbel PA Erlinge D Ohman EM 2012JAMA2012,308,17:1
15Faciliation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction:results from the SPEED(GUSTO_4 pilot)trial显示文摘HERRMANN H C MOLITERNO D J OHMAN E M 2000JACC2000,36,8:1
16Polyurethane biocidal polymeric surface modifiers显示文摘 Wood L Ohman D E 2006Biomaterials2006,27,:1
17Faciliatation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial显示文摘HEEMANN H C MOLITERNO D J OHMAN E M 2000J Am Coll Cardiol2000,36,6:1
18显示文摘Makal U Wood L Ohman D E 2006Biomaterials2006,27,8:1
19Use of cell wall stress to characterize sigma 22 (AlgT/U) activation by regulated proteolysis and its regulon in Pseudomonas aeruginosa显示文摘Wood L F Ohman D E 2009Mol Microbiol2009,72,1:1
20Facilitation of early precut-aneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED(GUSTO-4 Pilot)trial 显示文摘Herrmann H C Moliterno D J Ohman M 2000J Am Coll Cardiol2000,36,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费